Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Secondary Malignant Neoplasm of Bone”

939 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 939 results

Not applicableStudy completedNCT01833208
What this trial is testing

Radiation Therapy in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer Receiving Sipuleucel-T

Who this might be right for
Hormone-Resistant Prostate CancerMetastatic Malignant Neoplasm in the BoneRecurrent Prostate Carcinoma+1 more
Roswell Park Cancer Institute 15
Testing effectiveness (Phase 2)Looking for participantsNCT04282187
What this trial is testing

Decitabine With Ruxolitinib, Fedratinib or Pacritinib for the Treatment of Accelerated/Blast Phase Myeloproliferative Neoplasms

Who this might be right for
Acute Myeloid LeukemiaEssential ThrombocythemiaMyelodysplastic Syndrome+6 more
University of Washington 25
Not applicableLooking for participantsNCT02356497
What this trial is testing

Prospective Evaluation of Interventional Studies on Bone Metastases - the PRESENT Cohort

Who this might be right for
Bone Metastases
UMC Utrecht 2,500
Early research (Phase 1)Ended earlyNCT00996359
What this trial is testing

Partially HLA-Matched Irradiated Allogeneic Cellular Therapy After Reduced Intensity Total Body Irradiation

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more
University of Medicine and Dentistry of New Jersey 4
Large-scale testing (Phase 3)Study completedNCT01345019
What this trial is testing

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Patients With Multiple Myeloma

Who this might be right for
CancerHematologic MalignanciesMultiple Myeloma+3 more
Amgen 1,718
Not applicableStudy completedNCT03486431
What this trial is testing

A Dose-escalation Trial of Stereotactic Ablative Body Radiotherapy for Non-spine Bone & Lymph Node Oligometastates

Who this might be right for
Metastatic Cancer
Cancer Research Antwerp 90
Not applicableNot Yet RecruitingNCT06430411
What this trial is testing

Outcomes of Local Treatment for Oligometastatic Prostate Cancer Diagnosed Using PSMA PET Imaging: OLIGOMET Study

Who this might be right for
Prostate Cancer MetastaticProstate Cancer Metastatic to BoneProstate Cancer+3 more
Medical University of Vienna 500
Testing effectiveness (Phase 2)Study completedNCT00731328
What this trial is testing

Donor Stem Cell Transplant After Busulfan, Fludarabine, Methylprednisolone, and Antithymocyte Globulin in Treating Patients With Bone Marrow Failure Syndrome

Who this might be right for
LeukemiaMyelodysplastic SyndromesNonmalignant Neoplasm+1 more
Asan Medical Center 15
Large-scale testing (Phase 3)Study completedNCT02561039
What this trial is testing

Ibandronate (Bondronat) in Participants With Malignant Bone Disease

Who this might be right for
Pain; Bone Neoplasms; Neoplasm Metastasis
Hoffmann-La Roche 97
Testing effectiveness (Phase 2)Study completedNCT03204812
What this trial is testing

Durvalumab and Tremelimumab in Treating Chemotherapy Naive Patients With Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Castration-Resistant Prostate CarcinomaMetastatic Malignant Neoplasm in the BoneProstate Adenocarcinoma+3 more
M.D. Anderson Cancer Center 31
Not applicableLooking for participantsNCT05326919
What this trial is testing

The Patient Cohort of the National Center for Precision Medicine in Leukemia

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoblastic LeukemiaHigh-risk Myelodysplastic Syndrome+2 more
Assistance Publique - Hôpitaux de Paris 3,000
Not applicableLooking for participantsNCT06805812
What this trial is testing

Predicting clinicAL outcoMes During First-line CDK4/6 Inhibitors Plus Endocrine Therapy in Patients With Advanced Hormone REceptor-poSitive HER2-negative Breast Cancer: the Retrospective-prospective Multicenter Italian PALMARES-2 Study

Who this might be right for
Breast AdenocarcinomaBreast Cancer Stage IVBreast Cancer, Metastatic+38 more
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 3,500
Large-scale testing (Phase 3)Study completedNCT02711007
What this trial is testing

Apatinib for Advanced Osteosarcoma After Failure of Standard Multimodal Therapy

Who this might be right for
OsteosarcomaMetastasis
GUO WEI 37
Not applicableStudy completedNCT01254929
What this trial is testing

F-18 PET Bone Scans Versus Tc-99m Bone Scans for the Diagnosis of Bone Metastases

Who this might be right for
CancerBone Metastases
Seattle Nuclear Medicine 299
Not applicableStudy completedNCT03419442
What this trial is testing

Multi-academic Center Study of Xofigo Patients

Who this might be right for
Prostate Cancer, Castration Resistant
Bayer 150
Large-scale testing (Phase 3)Active Not RecruitingNCT05115331
What this trial is testing

Palliative UNConventional Hypofractionation Trial for Metastatic Bone Disease

Who this might be right for
Metastatic Bone Tumor
University of Cincinnati 168
Not applicableUnknownNCT02705157
What this trial is testing

The OPTIMAL Study - A Prospective Cohort of Patients With Bone Metastases of the Long Bones

Who this might be right for
Bone Metastasis
Leiden University Medical Center 900
Early research (Phase 1)Study completedNCT00004232
What this trial is testing

Bone Marrow and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer

Who this might be right for
Chronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+4 more
Northwestern University
Testing effectiveness (Phase 2)UnknownNCT02880943
What this trial is testing

Dose-finding, Safety and Efficacy Study of Radium-223 Dichloride (XOFIGO) in RCC Patients With Bone Metastases. (EIFFEL)

Who this might be right for
Clear-cell Metastatic Renal Cell CarcinomaBone Metastases
Association Pour La Recherche des Thérapeutiques Innovantes en Cancérologie 42
Early research (Phase 1)Study completedNCT01169584
What this trial is testing

Safety Study of Recombinant Vaccinia Virus to Treat Refractory Solid Tumors in Pediatric Patients

Who this might be right for
NeuroblastomaRhabdomyosarcomaLymphoma+2 more
Jennerex Biotherapeutics 6
Load More Results